Provided by Tiger Trade Technology Pte. Ltd.

Lunai Bioworks

1.38
-0.0900-6.12%
Post-market: 1.380.00000.00%19:41 EDT
Volume:38.32K
Turnover:55.67K
Market Cap:6.26M
PE:-0.02
High:1.60
Open:1.54
Low:1.38
Close:1.47
52wk High:13.28
52wk Low:1.21
Shares:4.53M
Float Shares:2.87M
Volume Ratio:0.71
T/O Rate:1.33%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-61.5200
EPS(LYR):-86.2743
ROE:-325.46%
ROA:-9.65%
PB:-0.65
PE(LYR):-0.02

Loading ...

Top News Today: Stocks Rise After Bond Market Flips in Choppy Trading

Dow Jones
·
5 hours ago

Lunai Bioworks Inc: Files for Non Timely 10-K with U.S. SEC

THOMSON REUTERS
·
Sep 30

Lunai Bioworks Inc: Anticipates Reporting a Net Loss for the Fiscal Year Ended June 30, 2026 of About $3.2 Million

THOMSON REUTERS
·
Sep 30

Lunai Bioworks Delays Annual Report Filing After Missing Form 10-K Deadline

Reuters
·
Sep 30

Lunai Bioworks Signs Exclusive Parkinson’s Cellular Phenotyping Deal with Tanaist

Reuters
·
Sep 22

Lunai Bioworks - to Own Collaboration-Generated Results and Intellectual Property

THOMSON REUTERS
·
Sep 22

Lunai Bioworks - Receives Exclusive Rights to Tanaist Cellular Phenotyping Technology for Parkinson's

THOMSON REUTERS
·
Sep 22

Lunai Bioworks (Nasdaq: Lnai) Expands Parkinson's Platform Through Exclusive Tanaist Agreement

THOMSON REUTERS
·
Sep 22

Lunai Bioworks Reports 0.88 AUROC in Structure-Based AChE Inhibitor Screening Model Using NIH Tox21 Data

Reuters
·
Sep 16

Lunai Bioworks Corrects Link to Second Amended Complaint in Naked Short Selling Suit Release

Reuters
·
Sep 04

Lunai Bioworks - Second Amended Complaint Alleges Securities Fraud and Market Manipulation Under Rule 10B-5

THOMSON REUTERS
·
Aug 27

Lunai Bioworks - Files Second Amended Complaint Naming Six Broker-Dealers and Two Principals

THOMSON REUTERS
·
Aug 27

Lunai Bioworks Lawsuit Names Six Broker-Dealers in Alleged Naked Short Selling Scheme

Reuters
·
Aug 27

Lunai Bioworks Signs Collaboration Agreement with BrainStorm Therapeutics on Parkinson’s Disease Research

Reuters
·
Aug 05

Lunai Bioworks - Initial Parkinson's Disease Data Readout Targeted for First Half of 2027

THOMSON REUTERS
·
Aug 05

Lunai Bioworks (Nasdaq: Lnai) Signs Definitive Collaboration Agreement with Brainstorm Therapeutics; Initial Parkinson's Disease Data Readout Targeted for First Half of 2027

THOMSON REUTERS
·
Aug 05

Lunai Bioworks Names 10 Defendants in Alleged Naked Short-Selling Fraud Lawsuit

Reuters
·
Aug 04

Lunai Bioworks announces availability of CEO shareholder letter

Reuters
·
Jun 17

Top Premarket Gainers

MT Newswires Live
·
Jun 17

Tianci International (CIIT) Stock Jumps Nearly 15% After Hours: Here's What Is Going On

Benzinga Earnings
·
Jun 17